High-Dose CD20-Targeted Radioimmunotherapy-Based Autologous Transplantation Improves Outcomes for Persistent Mantle Cell Lymphoma

Autologous stem cell transplant (ASCT) can improve outcomes for mantle cell lymphoma (MCL) patients, yet relapses are frequent. We hypothesized that high-dose anti-CD20 radioimmunotherapy (RIT)-based conditioning could improve results in this setting. We thus assessed 162 consecutive patients with M...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Br J Haematol
Main Authors: Cassaday, Ryan D., Stevenson, Philip A., Gooley, Theodore A., Chauncey, Thomas R., Pagel, John M., Rajendran, Joseph, Till, Brian G., Philip, Mary, Orozco, Johnnie J., Bensinger, William I., Holmberg, Leona A., Shustov, Andrei R., Green, Damian J., Smith, Stephen D., Libby, Edward N., Maloney, David G., Press, Oliver W., Gopal, Ajay K.
Formato: Artigo
Idioma:Inglês
Publicado em: 2015
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4715476/
https://ncbi.nlm.nih.gov/pubmed/26455717
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/bjh.13773
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados